nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.22	0.476	CbGbCtD
Eszopiclone—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.154	0.332	CbGbCtD
Eszopiclone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0894	0.193	CbGbCtD
Eszopiclone—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0312	0.0581	CcSEcCtD
Eszopiclone—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0179	0.0334	CcSEcCtD
Eszopiclone—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0307	CcSEcCtD
Eszopiclone—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0307	CcSEcCtD
Eszopiclone—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0241	CcSEcCtD
Eszopiclone—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0201	CcSEcCtD
Eszopiclone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0201	CcSEcCtD
Eszopiclone—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00936	0.0174	CcSEcCtD
Eszopiclone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00892	0.0166	CcSEcCtD
Eszopiclone—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.0162	CcSEcCtD
Eszopiclone—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00861	0.016	CcSEcCtD
Eszopiclone—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00831	0.0155	CcSEcCtD
Eszopiclone—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00797	0.0149	CcSEcCtD
Eszopiclone—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00779	0.0145	CcSEcCtD
Eszopiclone—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00744	0.0139	CcSEcCtD
Eszopiclone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.0134	CcSEcCtD
Eszopiclone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.0133	CcSEcCtD
Eszopiclone—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.013	CcSEcCtD
Eszopiclone—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.0129	CcSEcCtD
Eszopiclone—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.0129	CcSEcCtD
Eszopiclone—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.0128	CcSEcCtD
Eszopiclone—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.0128	CcSEcCtD
Eszopiclone—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.0128	CcSEcCtD
Eszopiclone—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.0067	0.0125	CcSEcCtD
Eszopiclone—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.0117	CcSEcCtD
Eszopiclone—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.0117	CcSEcCtD
Eszopiclone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.0113	CcSEcCtD
Eszopiclone—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.0113	CcSEcCtD
Eszopiclone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.011	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.0107	CcSEcCtD
Eszopiclone—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0056	0.0104	CcSEcCtD
Eszopiclone—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00543	0.0101	CcSEcCtD
Eszopiclone—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00992	CcSEcCtD
Eszopiclone—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.00942	CcSEcCtD
Eszopiclone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00921	CcSEcCtD
Eszopiclone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0049	0.00913	CcSEcCtD
Eszopiclone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00901	CcSEcCtD
Eszopiclone—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00475	0.00886	CcSEcCtD
Eszopiclone—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00871	CcSEcCtD
Eszopiclone—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00847	CcSEcCtD
Eszopiclone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.0084	CcSEcCtD
Eszopiclone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00833	CcSEcCtD
Eszopiclone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00833	CcSEcCtD
Eszopiclone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.00802	CcSEcCtD
Eszopiclone—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.00776	CcSEcCtD
Eszopiclone—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00409	0.00762	CcSEcCtD
Eszopiclone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00749	CcSEcCtD
Eszopiclone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.00747	CcSEcCtD
Eszopiclone—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00732	CcSEcCtD
Eszopiclone—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00704	CcSEcCtD
Eszopiclone—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00684	CcSEcCtD
Eszopiclone—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00676	CcSEcCtD
Eszopiclone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00666	CcSEcCtD
Eszopiclone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.00662	CcSEcCtD
Eszopiclone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00651	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.0064	CcSEcCtD
Eszopiclone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00636	CcSEcCtD
Eszopiclone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00634	CcSEcCtD
Eszopiclone—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00634	CcSEcCtD
Eszopiclone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00622	CcSEcCtD
Eszopiclone—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00615	CcSEcCtD
Eszopiclone—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00587	CcSEcCtD
Eszopiclone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00586	CcSEcCtD
Eszopiclone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00583	CcSEcCtD
Eszopiclone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00581	CcSEcCtD
Eszopiclone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00546	CcSEcCtD
Eszopiclone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00526	CcSEcCtD
Eszopiclone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00518	CcSEcCtD
Eszopiclone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.005	CcSEcCtD
Eszopiclone—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00499	CcSEcCtD
Eszopiclone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00495	CcSEcCtD
Eszopiclone—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.0049	CcSEcCtD
Eszopiclone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0048	CcSEcCtD
Eszopiclone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00478	CcSEcCtD
Eszopiclone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00473	CcSEcCtD
Eszopiclone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00471	CcSEcCtD
Eszopiclone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00469	CcSEcCtD
Eszopiclone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00466	CcSEcCtD
Eszopiclone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.0046	CcSEcCtD
Eszopiclone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00458	CcSEcCtD
Eszopiclone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00442	CcSEcCtD
Eszopiclone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0044	CcSEcCtD
Eszopiclone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00434	CcSEcCtD
Eszopiclone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00434	CcSEcCtD
Eszopiclone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00433	CcSEcCtD
Eszopiclone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00429	CcSEcCtD
Eszopiclone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00425	CcSEcCtD
Eszopiclone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.0042	CcSEcCtD
Eszopiclone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00416	CcSEcCtD
Eszopiclone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00413	CcSEcCtD
Eszopiclone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00402	CcSEcCtD
Eszopiclone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00397	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00379	CcSEcCtD
Eszopiclone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00376	CcSEcCtD
Eszopiclone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00374	CcSEcCtD
Eszopiclone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00371	CcSEcCtD
Eszopiclone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0037	CcSEcCtD
Eszopiclone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00366	CcSEcCtD
Eszopiclone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00362	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00359	CcSEcCtD
Eszopiclone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00359	CcSEcCtD
Eszopiclone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00356	CcSEcCtD
Eszopiclone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00356	CcSEcCtD
Eszopiclone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00343	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.0034	CcSEcCtD
Eszopiclone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00331	CcSEcCtD
Eszopiclone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00329	CcSEcCtD
Eszopiclone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00329	CcSEcCtD
Eszopiclone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00307	CcSEcCtD
Eszopiclone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00299	CcSEcCtD
Eszopiclone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00294	CcSEcCtD
Eszopiclone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00285	CcSEcCtD
Eszopiclone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00275	CcSEcCtD
Eszopiclone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00265	CcSEcCtD
Eszopiclone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00262	CcSEcCtD
Eszopiclone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00262	CcSEcCtD
Eszopiclone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00261	CcSEcCtD
Eszopiclone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00247	CcSEcCtD
